This study aimed to validate the Japanese version of the LupusPRO questionnaire for use with systemic lupus erythematosus patients.
Methods
Participants were 205 lupus patients recruited from three rheumatology centers in Japan. Demographic data were collected and quality of life was assessed using the LupusPRO and the Short Form Health Survey-12. Disease activity was evaluated by physicians using the Systemic Lupus Erythematosus Activity Index. Some participants completed questionnaires 10–14 days after the first survey. Internal consistency reliability, test-retest reliability, content validity and convergent validity were examined, and confirmatory factor analysis was performed.
Results
Participants’ mean age was 47.8 ± 13.6 years. Older participants scored lower on physical quality of life and higher on coping than younger participants. The LupusPRO showed satisfactory test-retest reliability (n = 111). Test-retest reliability was lower for the mental and social aspects of quality of life, indicating fluctuations in quality of life during the two-week interval. Internal consistency reliability was good and convergent validity with the corresponding domains of the Short Form Health Survey-12 was satisfactory. Confirmatory factor analysis showed a good model fit.
Conclusion
The Japanese LupusPRO is a reliable and valid measure to evaluate treatment interventions for systemic lupus erythematosus.
SutantoBGrewalDSMcNeilHP. Experiences and perspectives of adults living with systemic lupus erythematosus: Thematic synthesis of qualitative studies. Arthritis Care Res2013; 65: 1752–1765.
2.
ShakraM. Do improved survival rates of patients with systemic lupus erythematosus reflect a global trend?J Rheumatol2008; 35: 1906–1908.
3.
WolfeFMichaudKLiTKatzRS. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: Comparisons with rheumatoid arthritis, no inflammatory rheumatic disorders, and fibromyalgia. J Rheumatol2010; 37: 296–304.
4.
CastelinoMAbbottJMcElhoneKTehLS. Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: A review of the literature. Rheumatology2012; 52: 684–696.
5.
ChehabGCarnariusHSchneiderM. What matters for lupus patients?Presse Med2014; 3(6 Pt 2): e197–e207.
6.
HollowayLHumphreyLHeronL. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: A review of content validity, face validity and psychometric performance. Health Qual Life Outcomes2014; 12: 116–116.
7.
LeongKPKongKOThongBY. Development and preliminary validation of a systemic lupus erythematosus-specific quality of life instrument (SLEQOL). Rheumatology2005; 44: 1267–1276.
8.
McElhoneKAbbottJShelmerdineJ. Development and validation of a disease-specific health-related quality of life measure, the Lupus Qol, for adults with systemic lupus erythematosus. Arthritis Rheum2007; 57: 972–979.
9.
MosesNWiggersJNicholasCCockbunJ. Development and psychometric analysis of the systemic lupus erythematosus need questionnaire (SLENQ). Qual Life Res2006; 16: 461–466.
10.
DowardLCDowardLCMcKennaSP. The development of the L-QoL: A quality-of-life instrument specific to systemic erythematosus. Ann Rheum Dis2009; 68: 196–200.
JollyMGarrisCMikolaitisRA. Development and validation of the Lupus Impact Tracker: A patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus. Arthritis Care Res2014; 66: 1542–1550.
13.
JollyMKristinPFMikolaitisREvans-RaoulkKBlockJA. Body image intervention to improve health outcomes in lupus: A pilot study. J Clin Rheumatol2014; 20: 403–410.
14.
JollyMTolozaSBlockJ. Spanish LupusPRO: Cross-cultural validation study for lupus. Lupus2013; 22: 431–436.
15.
MokCCKosinskiMHoLYChanKLJollyM. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus. Arthritis Care Res2015; 67: 297–304.
16.
KayaAGokerBCuraES. Turkish lupusPRO: Cross-cultural validation study for lupus. Clin Rheumatol2014; 33: 1079–1084.
17.
Bourré-TessierJClarkeAEKosinskiM. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus. Lupus2014; 23: 1452–1459.
18.
NavarraSVTanangunanRMMikolaitis-PreussRAKosinskiMBlockJAJollyM. Cross-cultural validation of disease-specific patient-reported outcome measure for lupus in Philippines. Lupus2013; 22: 262–267.
19.
Bourré-TessierJClarkeAEMikolaitis-PreussRA. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol2013; 40: 1327–1333.
20.
SousaVDRojjanasriratW. Translation, adaptation and validation of instruments or scales for use in cross-cultural health care research: A clear and user-friendly guideline. J Eval Clin Pract2011; 17: 268–274.
21.
PolitDFBeckCT. The content validity index: Are you sure you know what’s being reported? Critique and recommendations. Res Nurs Health2006; 29: 489–497.
22.
AletahaDTuhinaNAlanSJ. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Ann Rheum Dis2010; 69: 1580–1588.
23.
FukuharaSSuzukamoY. Manual of SF-36v2 Japanese version, Kyoto: Institute for Health Outcomes & Process Evaluation Research, 2004.
24.
KarlsonEWLiangMHEatonH. A randomized clinical trial of a psychoeducational intervention to improve outcomes in systemic lupus erythematosus. Arthritis Rheum2002; 50: 1832–1841.
25.
BurnsNGroveSK. The Practice of nursing research conduct, critique, & utilization, 4th ed. Philadelphia: Sanders, 2001, pp. 396–396.
26.
AdayLA. Designing & conducting health surveys, 2nd ed. San Francisco: Jossey-Bass, 1996, pp. 53–53.
27.
StreinerDLNormanGR. Health measurement scales. A practical guide to their development and use, 4th ed. Oxford: Oxford University Press, 2008182.
28.
BoothH. Demographic forecasting: 1980 to 2005 in review. Int J Forecast2006; 22: 547–581.
29.
HaysRDAndersonRRevickiD. Psychometrics considerations in evaluating health-related quality of life measures. Qual Life Res1993; 2: 441–449.
30.
HuLBentlerPM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Modeling1998; 6: 1–55.
31.
JacksonDLGillaspyJAPurc-StephensonR. Reporting practice in confirmatory factor analysis: An overview and some recommendations. Psychol Methods2009; 14: 6–23.
32.
CarleACRileyWHaysRD. Confirmatory factor analysis of the patient reported outcomes measurement information system (PROMIS) adult domain framework using item response theory scores. Med Care2015; 53: 894–900.
33.
BarashPG. Clinical anesthesia, Philadelphia: Williams & Wilkins, 2013, pp. 199–199.
34.
RinaldiSDoriaASalaffiF. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship impact of age. Rheumatology2004; 43: 1574–1579.
35.
GouliaPVoulgariPVTsifetakiNDrososAAHyphantisT. Comparison of health-related quality of life and associated psychological factors between younger and older patients with established rheumatic disorders. Aging Ment Health2010; 14: 819–827.
36.
McDowellINewellC. Measuring health. A guide to rating scales and questionnaires, 2nd ed. Oxford: Oxford University Press, 1996, pp. 41–41.
37.
AlarcónGSMcGwinGJrBrooksK. Systemic lupus erythematosus in three ethnic groups. XI. Source of discrepancy in perception of disease activity: A comparison of physician and patients visual analog scale scores. Arthritis Rheum2002; 47: 408–413.
38.
JollyMUtsetTO. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?Lupus2004; 13: 924–926.
